New multi-centre research project launched
eRAPID is a 5 year multi-centre research project funded by the National Institute for Health Research (NIHR)
l-r Kate Absolom (Senior Research Fellow, Leeds Institute of Cancer and Pathology, LICAP), Lorraine Warrington (Research Assistant, LICAP), Trish Holch (Research Fellow, LICAP), Julian Hartley (Chief Executive, Leeds Teaching Hospitals NHS Trust), Galina Velikova (Professor of Psychosocial and Medical Oncology and Consultant in Medical Oncology, LICAP), Barbara Woroncow (eRAPID patient representative), Leon Bamforth (IT Manager in Health Informatics, LICAP)
The research will be carried out in three hospital sites; Leeds, Bristol and Manchester. During the programme a new online system to improve the monitoring and management of symptoms and side effects related to cancer treatment (chemotherapy, radiotherapy and surgery) will be evaluated. The online reports are immediately displayed in the patient hospital electronic records, so clinicians can use them to improve and streamline patient care. This is a truly unique feature of the eRAPID system. The aim of eRAPID is to improve the safe delivery of cancer treatment, enhance the patient experience and care and to standardise documentation of symptoms and side effects of treatments.
The eRAPID launch was successful in increasing awareness and knowledge of the programme prior to the commencement of pilot studies in all three centres between 2014 and 2016. A large scale randomised controlled trial is scheduled to take place in Leeds between 2015 and 2016.Posted in: University newsResearch and innovation